Prostate cancer risk and serum levels of insulin and leptin: A population-based study

Journal of the National Cancer Institute

Volumn 93, Issue 10, 2001, Pages 783-789

  Hsing, Ann W ^a,e   Chua Jr , Streamson ^b   Gao, Yu Tang ^c   Gentzschein, Elisabeth ^d   Chang, Lilly ^d   Deng, Jie ^c   Stanczyk, Frank Z ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c SHANGHAI CANCER INSTITUTE   (China)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; LEPTIN; SEX HORMONE; SOMATOMEDIN C;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY MASS; CANCER RISK; CHINA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY;

EID: 0035897513     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.10.783     Document Type: Article

References (58)

1. Rising incidence of prostate cancer in Shanghai, China
2. International trends and patterns of prostate cancer incidence and mortality
3. Impact of Westernization on the nutrition of Japanese: Changes in physique, cancer, longevity, and centenarians
4. An ecological study on diet/nutrition and cancer in Japan
5. Body size and prostate cancer: A population-based case-control study in China
6. Abdominal obesity is associated with insulin resistance
7. Intra-abdominal fat, lipid metabolism and insulin resistance in coronary artery disease
8. Body fat distribution, insulin resistance, and metabolic diseases
9. Metabolic implications of body fat distribution
10. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects
11. Central role of the adipocyte in the metabolic syndrome
12. Serum leptin in obesity is related to gender and body fat topography but does not predict successful weight loss
13. Leptin concentration in women is influenced by regional distribution of adipose tissue
14. Regulation of average 24h human plasma leptin level; the influence of exercise and physiological changes in energy balance
15. Evidence for leptin regulation of food intake in humans
16. Human leptin levels are pulsatile and inversely related to pituitary-adrenal function
17. Leptin concentrations, sex hormones, and cortisol in nondiabetic men
18. Leptin expression in adipose tissue from obese humans: Depot-specific regulation by insulin and dexamethasone
19. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men
20. Serum leptin concentration and insulin sensitivity in men with abdominal obesity
21. A study in the relationships between leptin, insulin, and body fat in Asian subjects
22. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: A population-based case-control study in China
23. Insulin-like growth factors and prostate cancer: A population-based case-control study in China
24. Radioimmunoassay of leptin in human plasma
25. Immunoassay of insulin: Two antibody system plasma insulin levels in normal subdiabetic and diabetic rats
26. Statistical methods in cancer research. Volume 1-The analysis of case-control studies
27. Leptin is associated with increased prostate cancer risk: A nested case-referent study
28. Leptin in relation to prostate cancer and benign prostatic hyperplasia
29. Leptin and prostate cancer
30. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
31. Insulin-like growth factor 1 and prostate cancer risk: A population-based, case-control study
32. Insulin-like growth factors and prostate cancer
33. Insulin-like growth factor-I and binding protein-3 and risk of cancer
34. Serum-free growth of adult human prostatic epithelial cells
35. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein
36. Up-regulation of IGF binding protein-1 as an anticarcinogenic strategy: Relevance to caloric restriction, exercise, and insulin sensitivity
37. Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance: Epidemiological and clinical correlation
38. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics
39. Gender differences in serum leptin in obese people: Relationships with testosterone, body fat distribution and insulin sensitivity
40. The relationship of insulin sensitivity and metabolic clearance of insulin to adiposity and sex hormone binding globulin
41. Diabetes mellitus and risk of prostate cancer
42. Is diabetes mellitus associated with prostate cancer incidence and survival?
43. Cancer risk in patients with diabetes mellitus
44. Heart disease risk factors, diabetes, and prostate cancer in an adult community
45. Risk factors for prostate cancer: A case-control study in Greece
46. Endogenous sex hormone levels in older adult men with diabetes mellitus
47. Insulin-like growth factor-I and insulin-like growth factor binding protein-1 in a representative population of type 2 diabetic patients in Sweden
48. Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men
49. Regional obesity and NIDDM
50. Evolution of beta-cell dysfunction in impaired glucose tolerance and diabetes
51. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults
52. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults
53. Overweight and obesity in the United States: Prevalence and trends, 1960-1994
54. Diagnosis of insulin resistance
55. How good a marker is insulin level for insulin resistance?
56. Homeostasis model assessment in a population with mixed ethnicity: The 1992 Singapore National Health Survey
57. Inhibition of bufalin on pituitary and testicular function in rats